Literature DB >> 18398587

Long-term results of radiotherapy in patients with chronic palmo-plantar eczema or psoriasis.

Marcin Sumila1, Markus Notter, Peter Itin, Stephan Bodis, Guenther Gruber.   

Abstract

BACKGROUND AND
PURPOSE: Radiotherapy (RT) is well accepted for therapy-refractory palmo-plantar eczema or psoriasis, despite of lacking evidence regarding beneficial long term effects. Furthermore, the optimal irradiation dose is unknown. We evaluated the outcome of RT with two different RT single/total dose (SD/TD) treatment policies. PATIENTS AND METHODS: 28 consecutive patients with therapy-refractory eczema (n = 22) or psoriasis (n = 6) of palms and/or soles were irradiated twice a week either with a D(max) SD of 1 Gy (6/98-5/03; median TD: 12 Gy) or 0.5 Gy (6/03-7/04; median TD: 5 Gy). Median age was 52 years (27-71), median follow-up 20 months (4-76). Totally 88 regions were treated, 49 with 1 Gy, 39 with 0.5 Gy SD. Eight different symptoms were scored from 0 (absent) -3 (severe), giving a possible sum score of 0-24. Patients' rating of RT result was also documented (worse/stable/better/complete remission).
RESULTS: The sum score was 15 (6-23) before RT, 2 (0-16) at the end of RT, and 1 (0-21) at last follow-up, respectively. The improvement was highly significant in both treatment regimens. Better or complete remission by the patients were reported in 44 and 39 (= 83 out of 88) localisations, that was often stable during the follow-up. 5 (6%) regions in 3 (11%) patients didn't benefit from RT.
CONCLUSION: RT reveals excellent results in palmo-plantar eczema or psoriasis. We recommend a SD of 0.5 Gy twice a week up to a TD of 4-5 Gy.

Entities:  

Mesh:

Year:  2008        PMID: 18398587     DOI: 10.1007/s00066-008-1788-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  7 in total

Review 1.  Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.

Authors:  Stephanie R McKeown; Paul Hatfield; Robin J D Prestwich; Richard E Shaffer; Roger E Taylor
Journal:  Br J Radiol       Date:  2015-10-14       Impact factor: 3.039

2.  Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years.

Authors:  Nicolas Betz; Oliver J Ott; Boris Adamietz; Rolf Sauer; Rainer Fietkau; Ludwig Keilholz
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

3.  [Radiotherapy in painful gonarthrosis. Results of a national patterns-of-care study].

Authors:  Ralph Mücke; M Heinrich Seegenschmiedt; Reinhard Heyd; Ulrich Schäfer; Franz-Josef Prott; Michael Glatzel; Oliver Micke
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

4.  Calcifying tendonitis of the shoulder joint : predictive value of pretreatment sonography for the response to low-dose radiotherapy.

Authors:  Boris Adamietz; Rüdiger Schulz-Wendtland; Sedat Alibek; Michael Uder; Rolf Sauer; Oliver Ott; Ludwig Keilholz
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

5.  Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas.

Authors:  Maria Grazia Fabrini; Franco Perrone; Lucia De Franco; Francesco Pasqualetti; Silvia Grespi; Riccardo Vannozzi; Luca Cionini
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

6.  Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosis.

Authors:  D Timerman; P M Devlin; V E Nambudiri; N A Wright; R A Vleugels; R A Clark; T S Kupper; J F Merola; M Patel
Journal:  Clin Exp Dermatol       Date:  2016-02-05       Impact factor: 3.470

7.  Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept.

Authors:  Amani Tresh; Victoria H Smith; Richard A G Parslew
Journal:  Libyan J Med       Date:  2012-10-11       Impact factor: 1.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.